Practice-Changing Data on Low ER+ Breast Tumors?

The immune landscape for low and intermediate estrogen receptor-positive breast tumors appears to mimic that for triple-negative tumors, suggesting a potential role for immunotherapy.
Medscape Medical News

source https://www.medscape.com/viewarticle/992641?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?